In order to assess the patency and function of biliary-enteric anastomoses performed in our Department of Surgery, 21 patients entered the following study, provided an informed consent was obtained. All the patients were affected by benign biliary tract diseases and underwent either Roux-en-Y hepaticojejunostomy (11 cases), or side-to-side choledochoduodenostomy (10 cases). The 21 patients were evaluated with Tc-99m-HIDA scanning at intervals of 20 days-36 months after the surgical procedure (mean 14 months). The images were obtained after intravenous injection of the radioactive medium (5 mCi) and the scans were taken at min (1 frame/s), 3 min (1 frame/10s), and 56 min (1 frame/2 min). The data were analyzed by a Digital PDP 11/34 Computer System. This method allowed us to assess each individual patient for the patency of the anastomosis and, by computer analysis, to build up a profile of the timing of the passage of the radioactive medium through the anastomosis; a delayed passage across the anastomosis was always pathological.
INTRODUCTION
Hepaticojejunostomy (HJ) and choledochoduodenostomy (CD) represent the most commonly used biliary enteric anastomoses for cholelithiasis and bile duct reconstructive surgery. Complications are relatively common; leakage and anastomotic breakdown usually present early on, whereas stenosis and cholangitis occur months or years after surgery2-4. The incidence of postoperative stenosis has been reported as 0.8-23% 4 There is considerable variability in the criteria chosen to assess the long-term results of biliary by-pass operations2'5'6: the follow-up usually reported is too short (< 2 years) and, even when adequate follow-up is provided, an The major weakness of cholescintigraphy is its limited anatomic resolution and inability to determine the nature of obstruction (stones, tumor relapse etc.).
Nevertheless, cholescintigraphy remains the best non-invasive method for routine assessment of patency or obstruction of a biliary-enteric anastomosis7'11'12.
The prognostic significance of cholescintigraphy requires further study but it may be valuable in this respect, as suggested in our patient with delayed intestinal excretion on early postoperative HIDA scan but with negative findings on laboratory tests and sonography. Whenever stenosis is suspected, PTC or ERC should be performed so as to define properly the anatomic pattern and to allow appropriate planning of re-operation.
INVITED COMMENTARY
The authors report that Tc-99m-HIDA scanning was useful in long-term follow-up of 21 patients with biliary-enteric anastomoses. They demonstrated a "good" result by scintigraphy in 18 patients, a "bad" result in two, and one "false positive." These results suggest a 95% accuracy for this non-invasive test. The authors state that scintigraphy may demonstrate abnormal function when biochemical tests of liver function and ultrasonic findings are normal. They also point out that, in comparison to endoscopic retrograde of percutaneous transhepatic cholangiography, HIDA scanning provides functional data and is safer and more comfortable. These advantages for scintigraphic evaluation of biliary-enteric anastomes-also apply in comparisons with computerized tomography, magnetic resonance imaging, and percutaneous liver biopsy.
In this study from the University of Naples, scans were taken at 1, 3 and 56 min after injection of the radionuclide. The two parameters evaluated were ductal dilatation and intestinal uptake at 1. Ductal dilatation, however, did not correlate very well with clinical outcome. Other parameters that were not studied were intestinal appearance time and hepatic uptake and clearance time and rate. Moreover, these latter data can be individually calculated for the right and left hepatic lobes. To obtain these additional data, scans need to be taken at more points in time during the first hour after injection, and counting has to be performed over specific areas of interest.
Theoretically, lobar hepatic uptake and clearance rates and intestinal appearance time would provide more data on biliary-enteric anastomotic function than the single parameter of gut uptake at 1. These additional data might be especially useful for following-up patients over time and in patients with hepatic parenchymal disease. Moreover, a significant percentage of patients who require biliary-enteric anastomoses have some degree of secondary biliary fibrosis or cirrhosis. In these patients, serial studies may also be helpful in assessment of both liver and anastomotic function over time.
Other ongoing issues in the management of patients with biliary-enteric anastomoses are the use of stents and the length of time for stenting. Scintigraphy should be able to provide quantitative data even when stents are in place. Thus, scans might be helpful with the decision to change or remove a stent. Scintigraphy could also be used to indicate when an indwelling endoprotheses is becoming occluded with biliary "sludge" and requires changing. This technique may also prove useful in the assessment of the results of balloon dilatation, and in the following-up of patients with sclerosing cholangitis.
In summary, iminodiacetic acid scintigraphy appears to be an excellent method for following patients with biliary enteric anastomoses. More data need to be obtained, however, on "normal" hepatic uptake and clearance rates and times, as well as on intestinal uptake time. Baseline scans should probably be performed approximately three months after surgery. In patients with long-term stents, follow-up scans can be done prior to and at three months after sten removal. In addition to serial liver function tests, scintigraphy should probably be performed on at least a yearly basis and whenever symptons or liver function tests suggest a problem. Even in the absence of symptoms, a significant change in function as determined by scintigraphy may warrant further workup including transhepatic cholangiography. With this algorithm, the hope is that anastomotic strictures will be detected and treated earlier and that further liver damage will be minimized. 
